Browsing by Author Kudo, Masatoshi
Showing results 1 to 8 of 8
Issue Date | Title | Author(s) |
---|---|---|
29-Feb-2024 | Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma | Llovet i Bayer, Josep Maria; Pinyol, Roser; Yarchoan, Mark; Singal, Amit G.; Marron, Thomas U.; Schwartz, Myron; Pikarsky, Eli; Kudo, Masatoshi; Finn, Richard S. |
13-Nov-2020 | Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2 | Kudo, Masatoshi; Galle, Peter R.; Brandi, Giovanni; Kang, Yoon Koo; Yen, Chia Jui; Finn, Richard S.; Llovet i Bayer, Josep Maria; Assenat, Eric; Merle, Philippe; Chan, Stephen L.; Palmer, Daniel H.; Ikeda, Masafumi; Yamashita, Tatsuya; Vogel, Arndt; Huang, Yi Hsiang; Abada, Paolo; Yoshikawa, Reigetsu; Shinozaki, Kenta; Wang, Chunxiao; Widau, Ryan C.; Zhu, Andrew X. |
24-Mar-2021 | NASH limits anti-tumour surveillance in immunotherapy-treated HCC | Pfister, Dominik; Nunez, Nicolas Gonzalo; Pinyol, Roser; Govaere, Olivier; Pinter, Matthias; Szydlowska, Marta; Gupta, Revant; Qiu, Mengjie; Deczkowska, Aleksandra; Weiner, Assaf; Mueller, Florian; Malek, Nisar; Spahn, Stephan; Bitzer, Michael; Ruiz de Galarreta, Marina; Lujambio, Amaia; Dufour, Jean-Francois; Marron, Thomas U.; Kaseb, Ahmed; Kudo, Masatoshi; Huang, Yi Hsiang; Djouder, Nabil; Wolter, Katharina; Zender, Lars; Marche, Parice N.; Decaens, Thomas; Pinato, David J.; Rad, Roland; Mertens, Joachim C.; Weber, Achim; Unger, Kristian; Meissner, Felix; Roth, Susanne; Jilkova, Zuzana Macek; Claassen, Manfred; Anstee, Quentin M.; Amit, Ido; Knolle, Percy; Becher, Burkhard; Llovet i Bayer, Josep Maria; Heikenwälder, Mathias; Sinha, Ankit; Friebel, Ekaterina; Engleitner, Thomas; Lenggenhager, Daniela; Moncsek, Anja; Heide, Danijela; Stirm, Kristin; Kosla, Jan; Kotsiliti, Eleni; Leone, Valentina; Dudek, Michael; Yousuf, Suhail; Inverso, Donato; Singh, Indrabahadur; Teijeiro, Ana; Castet, Florian; Montironi, Carla; Haber, Philipp K.; Tiniakos, Dina; Bedossa, Pierre; Cockell, Simon; Younes, Ramy; Vacca, Michele; Marra, Fabio; Schattenberg, Jörn M.; Allison, Michael; Bugianesi, Elisabetta; Ratziu, Vlad; Pressiani, Tiziana; D'Alessio, Antonio; Personeni, Nicola; Rimassa, Lorenza; Daly, Ann K.; Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M.; Vogel, Arndt; Peck-Radosavljevic, Markus; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Trojan, Jorg; Schulze, Kornelius; Wege, Henning; Koch, Sandra; Weinmann, Arndt; Bueter, Marco; Rossler, Fabian; Siebenhuner, Alexander; De Dosso, Sara; Mallm, Jan Philipp; Umansky, Viktor; Jugold, Manfred; Luedde, Tom; Schietinger, Andrea; Schirmacher, Peter; Emu, Brinda; Augustin, Hellmut G.; Billeter, Adrian; Mueller-Stich, Beat; Kikuchi, Hiroto; Duda, Dan G.; Kutting, Fabian; Waldschmidt, Dirk-Thomas; Ebert, Matthias Philip; Rahbari, Nuh; Mei, Henrik E.; Schulz, Axel Ronald; Ringelhan, Marc |
25-Jan-2017 | Objective response by mRECIST as a predictor and potential surrogate end point of overall survival in advanced HCC | Lencioni, Riccardo; Montal, Robert; Torre, Ferran; Park, Joong-Won; Decaens, Thomas; Raoul, Jean-Luc; Kudo, Masatoshi; Chang, Charissa Y.; Ríos, José; Boige, Valerie; Assenat, Eric; Kang, Yoon-Koo; Lim, Ho-Yeong; Walters, Ian; Llovet i Bayer, Josep Maria |
14-Nov-2020 | Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab | Reig, María; Galle, Peter R.; Kudo, Masatoshi; Finn, Richard; Llovet i Bayer, Josep Maria; Metti, Andrea L.; Schelman, William R.; Liang, Kun; Wang, Chunxiao; Widau, Ryan C.; Abada, Paolo; Zhu, Andrew X. |
27-Jul-2020 | Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma | Finn, Richard S.; Ikeda, Masafumi; Zhu, Andrew X.; Sung, Max W.; Baron, Ari D.; Kudo, Masatoshi; Okusaka, Takuji; Kobayashi, Masahiro; Kumada, Hiromitsu; Kaneko, Shuichi; Pracht, Marc; Mamontov, Konstantin; Meyer, Tim; Kubota, Tomoki; Dutcus, Corina E.; Saito, Kenichi; Siegel, Abby B.; Dubrovsky, Leonid; Mody, Kalgi; Llovet i Bayer, Josep Maria |
Aug-2020 | Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2 | Kudo, Masatoshi; Galle, Peter R.; Llovet i Bayer, Josep Maria; Finn, Richard S.; Vogel, Arndt; Motomura, Kenta; Assenat, Eric; Merle, Philippe; Brandi, Giovanni; Daniele, Bruno; Okusaka, Takuji; Tomášek, Jiří; Borg, Christophe; Dadduzio, Vincenzo; Morimoto, Manabu; Pracht, Marc; Jen, Min-Hua; Widau, Ryan C.; Shinozaki, Kenta; Yoshikawa, Reigetsu; Zhu, Andrew X. |
1-Jan-2020 | Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials | Zhu, Andrew X.; Nipp, Ryan D.; Finn, Richard S.; Galle, Peter R.; Llovet i Bayer, Josep Maria; Blanc, Jean Frederic; Okusaka, Takuji; Chau, Ian; Cella, David; Girvan, Alicia; Gable, Jonathon; Bowman, Lee; Wang, Chunxiao; Hsu, Yanzhi; Abada, Paolo; Kudo, Masatoshi |